|
29/08/2024
|
Company update: "Proactive cut in SC revenue from RW>2" – Outperform (TP Bt21)
|
|
16/08/2024
|
Earnings brief: "2Q24: Below estimates on SC write-off" – Outperform (TP Bt23)
|
|
18/07/2024
|
Company update: "Earnings cut to factor in slow Kuwaiti patients" – Outperform (TP Bt23)
|
|
04/06/2024
|
High conviction: "Clear growth ahead, negative priced in" – Outperform (TP Bt25)
|
|
17/05/2024
|
Earnings brief: "1Q24: In line with estimates" – Outperform (TP Bt25)
|
|
02/05/2024
|
Company update: "Preview 1Q24F: Slow quarter, better ahead." – Outperform (TP Bt25)
|
|
18/03/2024
|
Company update: "Strong growth in 2024" – Outperform (TP Bt25)
|
|
04/03/2024
|
Earnings Brief: "4Q23: Net profit in line" – Outperform (TP Bt24)
|
| |
|
| |
|
FOLLOW US
SCB's Facbook INVX's Twitter